Pooled ATTAIN-1 and ATTAIN-2 results showed about 14% average weight loss and up to 12.5 cm off the waist across menopausal stages.
Recap by typeshit. Full story at Blavity News.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Experts quoted in the piece suggest the spread of GLP-1 drugs could shape how non-users feel about their own bodies and health.
The FDA put both companies on an import alert, which lets it stop their products at the US border, News Nation reports.
Loading…